Ozempic Tablet
Product Images NDC 0169-1715

9 FDA label images from Novo Nordisk Pharmaceutical Industries, Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ozempic (NDC 0169-1715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk Pharmaceutical Industries, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure diagram showing the molecular structure of the active ingredient in RYBELSUS. The diagram includes labeled amino acid residues and a lipid side chain, illustrating the peptide and chemical modifications present in the molecule.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
A forest plot chart illustrating the relative exposure ratio and 90% confidence intervals (CI) of RYBELSUS across various intrinsic factors such as sex, age group, race, ethnicity, body weight, presence of upper GI disease, and renal function. The chart shows comparisons between subgroups for each factor, with a reference line at 1.0 indicating baseline exposure.*
FDA Label Image

3mg Bottle (Image 03)

3mg Bottle (Image 03)
RYBELSUS 3 mg (semaglutide) tablets packaging label for oral use, once daily, by Novo Nordisk Pharmaceutical Industries, LP. The label shows a 30-tablet bottle with instructions to dispense with a medication guide. It includes storage instructions and warnings to take on an empty stomach with no more than 4 ounces of water, and to wait 30 minutes before eating or taking other medications. The package insert and patent information URLs are also visible.*
FDA Label Image

Figure 4 (Image 05)

Figure 4 (Image 05)
A forest plot showing relative exposure ratios and 90% confidence intervals for various co-administered medications with RYBELSUS. The chart includes drugs such as Lisinopril, S-warfarin, R-warfarin, Metformin, Digoxin, Ethinylestradiol, Levonorgestrel, Furosemide, Rosuvastatin, and Levothyroxine, comparing parameters like AUC and Cmax ratios around a reference value of 1.*
FDA Label Image

3mg Trade (Image 08)

3mg Trade (Image 08)
RYBELSUS 3 mg (semaglutide) Tablets packaging label showing a white and green carton with branding and dosage information. The label indicates the product contains 30 tablets, is for oral use only, and is manufactured by Novo Nordisk Pharmaceutical Industries, LP. Directions include once daily oral use and a note to dispense the enclosed medication guide to each patient.*
FDA Label Image

7mg Trade (Image 09)

7mg Trade (Image 09)
Packaging label for RYBELSUS 7 mg (semaglutide) tablets by Novo Nordisk Pharmaceutical Industries, LP. The label indicates oral use, once daily dosing, and that the package contains 30 tablets in 3 blister packs of 10 tablets each. It includes instructions to dispense the enclosed medication guide to patients and features the Novo Nordisk logo.*
FDA Label Image

14mg Trade (Image 10)

14mg Trade (Image 10)
Packaging label for RYBELSUS 14 mg (semaglutide) tablets by Novo Nordisk Pharmaceutical Industries, LP. The label indicates oral use, once daily dosing, and contains 30 tablets in 3 blister packs. The design features branding elements with a blue and yellow sunburst graphic.*
FDA Label Image

7 Bottle (Image 12)

7 Bottle (Image 12)
RYBELSUS 7 mg (semaglutide) tablets packaging label shows a 30-tablet bottle containing oral tablets for once-daily use. The label includes directions to take on an empty stomach with no more than 4 ounces of water and to wait 30 minutes before other oral intake. It is labeled for Rx only and dispensed with a medication guide. Manufactured and labeled by Novo Nordisk Pharmaceutical Industries, LP.*
FDA Label Image

14 Bottle (Image 13)

14 Bottle (Image 13)
RYBELSUS 14 mg (semaglutide) tablets carton from Novo Nordisk Pharmaceutical Industries, LP. The label indicates oral once-daily dosage with 30 tablets per package. Directions emphasize taking on an empty stomach with no more than 4 ounces of water, waiting 30 minutes before eating or taking other medications. The label includes storage and disposal instructions, ingredients, and a medication guide reminder. The design features a blue and white color scheme with Novo Nordisk branding and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.